Kamada (XTAE:KMDA) Change In Inventory : ₪-16.9 Mil (TTM As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Kamada Change In Inventory?

Kamada's change in inventory for the quarter that ended in Mar. 2024 was ₪15.2 Mil. It means Kamada's inventory declined by ₪15.2 Mil from Dec. 2023 to Mar. 2024 .

Kamada's change in inventory for the fiscal year that ended in Dec. 2023 was ₪-72.4 Mil. It means Kamada's inventory increased by ₪72.4 Mil from Dec. 2022 to Dec. 2023 .

Kamada's Total Inventories for the quarter that ended in Mar. 2024 was ₪309.9 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Kamada's Days Inventory for the quarter that ended in Mar. 2024 was 375.76.

Inventory Turnover measures how fast the company turns over its inventory within a year. Kamada's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.24.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Kamada's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 2.29.

Kamada Change In Inventory Historical Data

The historical data trend for Kamada's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kamada Change In Inventory Chart

Kamada Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-50.91

4.25

-8.72

-5.00

-72.35

Kamada Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial															-40.30	-1.77	23.66	-53.94	15.18

Kamada Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪-16.9 Mil.

Kamada (XTAE:KMDA) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Kamada's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	317.4705	/	77.095	*	365 / 4
	=	375.76

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Kamada's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	77.095	/	317.4705
	=	0.24

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Kamada's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	317.4705	/	138.636
	=	2.29

Kamada Change In Inventory Related Terms

Thank you for viewing the detailed overview of Kamada's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Kamada (XTAE:KMDA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kamada Ltd (XTAE:KMDA) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

KMDA:USA

Address

2 Holzman Street, P.O. Box 4081, Science Park, Rehovot, ISR, 7670402

Website

https://www.kamada.com

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.